BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31843588)

  • 1. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
    Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
    Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma.
    Barrau M; Maoui K; Le Roy B; Roblin X; Mismetti P; Phelip JM; Williet N
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3447-3454. PubMed ID: 33715087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous Thromboembolism in Patients with Advanced Pancreatic Cancer Receiving Palliative Chemotherapy: Incidence and Effect on Prognosis.
    Jeong HT; Bae JH; Kim HG; Han J
    Korean J Gastroenterol; 2023 Mar; 81(3):109-120. PubMed ID: 36960693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of venous thromboembolism in women with cervical cancer.
    Matsuo K; Moeini A; Machida H; Fullerton ME; Shabalova A; Brunette LL; Roman LD
    Gynecol Oncol; 2016 Sep; 142(3):405-12. PubMed ID: 27350404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
    Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
    J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
    Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma.
    Ouaissi M; Frasconi C; Mege D; Panicot-Dubois L; Boiron L; Dahan L; Debourdeau P; Dubois C; Farge D; Sielezneff I
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):436-42. PubMed ID: 26256090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study.
    Lee JC; Ro YS; Cho J; Park Y; Lee JH; Hwang JH; Choi HJ; Lee S
    Medicine (Baltimore); 2016 Apr; 95(17):e3472. PubMed ID: 27124043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients.
    Mandalà M; Reni M; Cascinu S; Barni S; Floriani I; Cereda S; Berardi R; Mosconi S; Torri V; Labianca R
    Ann Oncol; 2007 Oct; 18(10):1660-5. PubMed ID: 17660490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous Thromboembolism in Japanese Patients With Pancreatic Cancer.
    Suzuki T; Hori R; Takeuchi K; Yamamura R; Katoh H; Noji Y; Yamaguchi M; Fujino S
    Clin Appl Thromb Hemost; 2021; 27():10760296211051766. PubMed ID: 34730013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
    Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.
    Dadi N; Stanley M; Shahda S; O'Neil BH; Sehdev A
    Anticancer Res; 2017 Oct; 37(10):5533-5539. PubMed ID: 28982867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
    Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients.
    Mohindroo C; Hasanov M; Rogers JE; Dong W; Prakash LR; Baydogan S; Mizrahi JD; Overman MJ; Varadhachary GR; Wolff RA; Javle MM; Fogelman DR; Lotze MT; Kim MP; Katz MHG; Pant S; Tzeng CD; McAllister F
    Cancer Med; 2021 Aug; 10(15):5041-5050. PubMed ID: 34250759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.
    Oto J; Navarro S; Larsen AC; Solmoirago MJ; Plana E; Hervás D; Fernández-Pardo Á; España F; Kristensen SR; Thorlacius-Ussing O; Medina P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative cognitive function predicts survival in patients with resectable pancreatic ductal adenocarcinoma.
    Baekelandt BM; Hjermstad MJ; Nordby T; Fagerland MW; Kure EH; Heiberg T; Buanes T; Labori KJ
    HPB (Oxford); 2016 Mar; 18(3):247-54. PubMed ID: 27017164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
    Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
    Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma.
    Poruk KE; Firpo MA; Huerter LM; Scaife CL; Emerson LL; Boucher KM; Jones KA; Mulvihill SJ
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2605-10. PubMed ID: 20729288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer.
    Menapace LA; Peterson DR; Berry A; Sousou T; Khorana AA
    Thromb Haemost; 2011 Aug; 106(2):371-8. PubMed ID: 21713322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative venous thromboembolism and mortality in patients with pancreatic surgery.
    Majmudar K; Quintero LD; Fuentes HE; Stocker S; Tafur AJ; Lee CJ; Talamonti M
    J Surg Oncol; 2019 Sep; 120(3):494-500. PubMed ID: 31222842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.